Single-Cell Barcode Labeling for B Cell Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccines struggle to induce antibodies against conserved viral epitopes of rapidly mutating pathogens like HIV-1 and influenza, leading to polyclonal responses that interfere with broad protection, and there is a lack of techniques to identify and manipulate B cells for mature antibody production.
Innovation Solution
A method involving cells labeled with exogenous barcodes using gene-editing enzymes to integrate a barcode into the endogenous DNA of B cells, allowing tracking and identification of antigen-specific B cells through sequential immunization, which can guide vaccine design.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vaccination methods are used to induce antibody responses, then polyclonal antibody responses are generated, but these responses target non-conserved epitopes and interfere with broad protective immunity
Solution Approach 1:
The patent segments the B cell population by introducing unique genetic barcodes that allow individual tracking of specific B cell clones. This segmentation enables researchers to distinguish between different B cell populations and their antibody specificities, thereby identifying and selecting for antibodies targeting conserved epitopes while excluding those targeting non-conserved epitopes that cause interference.
Solution Approach 2:
The patent uses genetic barcodes as intermediaries to link specific B cell clones to their antibody products. These barcodes serve as mediators that enable the tracking and selection of B cells producing antibodies against conserved epitopes, allowing researchers to guide the immune response away from harmful polyclonal responses to beneficial targeted responses.
2Reliability
If sequential immunization with engineered immunogens is performed to induce mature antibodies, then antibody maturity and neutralization capacity improve, but the process complexity and time required increase
Solution Approach 1:
The patent applies preliminary action by pre-introducing genetic barcodes into B cells before immunization. This allows for the prospective tracking and identification of B cell clones that will undergo somatic hypermutation and produce high-affinity antibodies, thereby simplifying the overall process by enabling targeted selection of matured B cells without requiring complex sequential immunization protocols.
Solution Approach 2:
The patent implements feedback mechanisms by using the genetic barcodes to monitor and track the evolution of B cell clones throughout the immunization process. This feedback allows researchers to identify which clones are undergoing productive somatic hypermutation and are generating high-affinity antibodies, enabling optimized immunization strategies that reduce complexity while maintaining effectiveness.
3Measurement precision
If techniques are developed to track and manipulate B cells for mature antibody production, then identification and isolation of mature antibodies improve, but the technical complexity and difficulty of detection increase
Solution Approach 1:
The patent uses genetic barcodes as informational copies that represent specific B cell clones. These barcodes are integrated into the genome of individual B cells and can be amplified and detected independently of the actual B cells, allowing for precise identification and tracking of specific clones through sequencing and other detection methods without requiring direct manipulation of the cells themselves.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the tracking of antigen-specific B cells, illuminating mechanisms of epitope immunodominance and memory B cell reactivation, facilitating the development of efficacious vaccines against highly mutating pathogens.
Implementation Method 1
the endogenous DNA of the cell is modified to include a region of exogenous barcode DNA sequence from the nucleic acid molecule
Data Source
AI summary
The disclosure provides materials and methods for permanently labeling cells by transducing cells with viruses comprising a barcode. The disclosure is based on the idea that tracking, selecting and isolating lymphocytes labeled with the barcode can facilitate identification of clonal cells responsible for antibody or antibody fragment production.